Back to Browse Journals » Neuropsychiatric Disease and Treatment » Volume 2 » Issue 3

Religiosity in patients with Parkinson's disease

Authors Patrick McNamara, Raymon Durso, Ariel Brown

Published 15 September 2006 Volume 2006:2(3) Pages 341—348

Patrick McNamara, Raymon Durso, Ariel Brown

Department of Neurology, Boston University School of Medicine, Boston, MA, and VA Boston Healthcare System, Boston, MA, USA

Objective: To study clinical correlates of religiosity in Parkinson’s disease (PD).

Methods: Measures of life goals, religiosity, mood, and neuropsychologic function were assessed in 22 persons with mid-stage PD and 20 age-matched healthy controls. Levodopa dose equivalents (LDE) were also computed for the patients.

Results: Relative to other major life goals parkinsonian patients were significantly more likely to report that “my religion or life philosophy” was less important than were age-matched controls. Scores on a battery of religiosity scales were consistently lower for Parkinson’s patients than those of age-matched controls. While Mini Mental State Exam, logical memory recall, Stroop, and selected (depression and anxiety) mood scales reliably distinguished patients from controls, only measures of prefrontal function correlated with religiosity scores.

Conclusions: Patients with PD express less interest in religion and report consistently lower scores on measures of religiosity than age-matched controls. Prefrontal dopaminergic networks may support motivational aspects of religiosity.

Keywords: religiosity, Parkinson’s disease, neuropsychology, mood, executive functions, dopamine agonists

Download Article [PDF] 

Readers of this article also read:

Development of a liposome-based formulation for vitamin K1 nebulization on the skin

Campani V, Marchese D, Pitaro MT, Pitaro M, Grieco P, De Rosa G

International Journal of Nanomedicine 2014, 9:1823-1832

Published Date: 10 April 2014

Stem cell tracking using iron oxide nanoparticles

Bull E, Madani SY, Sheth R, Seifalian A, Green M, Seifalian AM

International Journal of Nanomedicine 2014, 9:1641-1653

Published Date: 31 March 2014

Perioperative hyperglycemia is associated with postoperative neurocognitive disorders after cardiac surgery

Zhang X, Yan X, Gorman J, Hoffman SN, Zhang L, Boscarino JA

Neuropsychiatric Disease and Treatment 2014, 10:361-370

Published Date: 19 February 2014

The safety and efficacy of aspirin intake in photoselective vaporization laser treatment of benign prostate hyperplasia

Shao IH, Hou CP, Chen SM, Chen CL, Lin YH, Chang PL, Tsui KH

Clinical Interventions in Aging 2013, 8:431-432

Published Date: 16 April 2013

The association of C3435T single-nucleotide polymorphism, Pgp-glycoprotein gene expression levels and carbamazepine maintenance dose in patients with epilepsy

Sterjev Z, Trencevska GK, Cvetkovska E, Petrov I, Kuzmanovski I, Ribarska JT, Nestorovska AK, Matevska N, Naumovska Z, Jolevska-Trajkovic S, Dimovski A, Suturkova L

Neuropsychiatric Disease and Treatment 2012, 8:191-196

Published Date: 19 April 2012

Erratum - Intracellular heavy metal nanoparticle storage

Iannitti T, Capone S, Gatti A, et al

International Journal of Nanomedicine 2011, 6:239-240

Published Date: 26 January 2011

Update on the use of pramipexole in the treatment of Parkinson’s disease

Radu Constantinescu

Neuropsychiatric Disease and Treatment 2008, 4:337-352

Published Date: 11 April 2008

Continuous levodopa for advanced Parkinson’s disease

Christofer Lundqvist

Neuropsychiatric Disease and Treatment 2007, 3:335-348

Published Date: 15 July 2007